Generics News

Generics News

Amneal Launches Generic Activella

Amneal announced the launch of Lopreeza (estradiol and norethindrone acetate) tablets, the generic version of Novo Nordisk's Activella.

Generic Valcyte Launched by Endo

Endo announced the launch of Valganciclovir Tablets, the first generic version of Roche's Valcyte to be available in the U.S.

Dr. Reddy's Launches Generic Allegra-D 12 Hour

Dr. Reddy's Laboratories announced the launch of Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets, the generic version of Chattem's Allegra-D 12 Hour.

Teva Launches Generic Lovenox Injection

Teva announced the launch of Enoxaparin Sodium Injection, the generic version of Sanofi Aventis' Lovenox.

Teva Launches New Generic Focalin XR Strength

Teva announced the availability of a new 5mg strength of Dexmethylphenidate HCl Extended-Release (ER) Capsules, the generic version of Focalin XR Extended-Release Capsules.

Endo Approved for Generic Valcyte

Endo announced that Qualitest, its subsidiary, has received final approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets, the generic version of Roche's Valcyte.

Hospira Launches Generic Zemplar Injection

Hospira announced the launch of Paricalcitol Injection, the generic version of AbbVie's Zemplar.

Ranbaxy Approved for Generic Antara

Ranbaxy Laboratories announced that it has received approval from the Food and Drug Administration (FDA) for manufacturing and marketing of Fenofibrate Capsules, the generic equivalent of Lupin's Antara.

Mylan Launches Generic Loestrin 24 Fe

Mylan announced that it has received final approval for Norethindrone Acetate and Ethinyl Estradiol Tablets, 1mg/0.02mg and Ferrous Fumarate, the generic version of Warner Chilcott's Loestrin 24 Fe.

Breckenridge Approved for Generic Seroquel

Breckenridge announced that the Food and Drug Administration (FDA) has approved Quetiapine Fumarate Tablets, the generic version of AstraZeneca's Seroquel.